These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34352138)

  • 1. A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults.
    Bullock A; Gunduz-Bruce H; Zammit GK; Qin M; Li H; Sankoh AJ; Silber C; Kanes SJ; Jonas J; Doherty J
    Hum Psychopharmacol; 2022 Jan; 37(1):e2806. PubMed ID: 34352138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
    Furey SA; Hull SG; Leibowitz MT; Jayawardena S; Roth T
    J Clin Sleep Med; 2014 Oct; 10(10):1101-9. PubMed ID: 25317091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials.
    Huang Z; Zhan S; Chen C; Zhang R; Zhou Y; He J; Lin Z; Bao C; Zhu S; Zhao J; Zhang S; Jiang Y; Wang Y
    Sleep; 2024 Feb; 47(2):. PubMed ID: 37875349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials.
    Mignot E; Mayleben D; Fietze I; Leger D; Zammit G; Bassetti CLA; Pain S; Kinter DS; Roth T;
    Lancet Neurol; 2022 Feb; 21(2):125-139. PubMed ID: 35065036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study.
    Li Y; Zhang R; Zhou Y; Bao C; Lin Z; Chen C; He J; Jin Z; Song L; Zhang M; Guo S; Jiang Y; Zhao Z
    Sleep; 2024 Feb; 47(2):. PubMed ID: 37864827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
    Krystal AD; Durrence HH; Scharf M; Jochelson P; Rogowski R; Ludington E; Roth T
    Sleep; 2010 Nov; 33(11):1553-61. PubMed ID: 21102997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
    Fietze I; Bassetti CLA; Mayleben DW; Pain S; Seboek Kinter D; McCall WV
    Drugs Aging; 2022 Oct; 39(10):795-810. PubMed ID: 36098936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
    Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
    Rosenberg RP; Hull SG; Lankford DA; Mayleben DW; Seiden DJ; Furey SA; Jayawardena S; Roth T
    J Clin Sleep Med; 2014 Oct; 10(10):1093-100. PubMed ID: 25317090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of SM-1 in a transient insomnia model.
    Dahl T; Chen LB; Zammit G; Ahmad M; Roth T
    Hum Psychopharmacol; 2019 Nov; 34(6):e2713. PubMed ID: 31837050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
    Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.
    Scharf M; Rogowski R; Hull S; Cohn M; Mayleben D; Feldman N; Ereshefsky L; Lankford A; Roth T
    J Clin Psychiatry; 2008 Oct; 69(10):1557-64. PubMed ID: 19192438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.
    Ivgy-May N; Ruwe F; Krystal A; Roth T
    Sleep Med; 2015 Jul; 16(7):838-44. PubMed ID: 26047892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.
    Lankford DA; Corser BC; Zheng YP; Li Z; Snavely DB; Lines CR; Deacon S
    Sleep; 2008 Oct; 31(10):1359-70. PubMed ID: 18853933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
    Roth T; Seiden D; Wang-Weigand S; Zhang J
    Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.
    Roth T; Rogowski R; Hull S; Schwartz H; Koshorek G; Corser B; Seiden D; Lankford A
    Sleep; 2007 Nov; 30(11):1555-61. PubMed ID: 18041488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo.
    Walsh JH; Maddison KJ; Rankin T; Murray K; McArdle N; Ree MJ; Hillman DR; Eastwood PR
    Sleep; 2021 Nov; 44(11):. PubMed ID: 34115851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study.
    Roth T; Wright KP; Walsh J
    Sleep; 2006 Mar; 29(3):335-41. PubMed ID: 16553019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.